story of the week
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial
JAMA Oncol 2018 Jun 28;[EPub Ahead of Print], VF Borges, C Ferrario, N Aucoin, C Falkson, Q Khan, I Krop, S Welch, A Conlin, J Chaves, PL Bedard, M Chamberlain, T Gray, A Vo, E HamiltonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.